Variable | DFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Univariate | ||||||
Sex (women vs. men) | 0.820 | 0.532–1.265 | 0.370 | 0.853 | 0.549–1.324 | 0.478 |
Age (<65 years vs. ≥65 years) | 1.088 | 0.659–1.797 | 0.741 | 0.984 | 0.583–1.661 | 0.953 |
Liver cirrhosis (yes vs. no) | 1.410 | 0.706–2.816 | 0.331 | 1.055 | 0.508–2.191 | 0.885 |
EYA4 protein expressiona (≤3.4 vs. >3.4) | 2.635 | 1.684–4.122 | <0.001 | 2.730 | 1.727–4.314 | <0.001 |
CA19-9 (>37 U/L vs. ≤37 U/L) | 1.753 | 1.107–2.778 | 0.017 | 1.955 | 1.214–3.147 | 0.006 |
CEA (>5 µg/L vs. ≤5 µg/L) | 1.665 | 1.077–2.574 | 0.022 | 1.764 | 1.128–2.758 | 0.013 |
Size of tumor (≤5 cm vs. >5 cm) | 0.983 | 0.631–1.529 | 0.938 | 1.047 | 0.667–1.643 | 0.841 |
Number of tumors (multiple vs. single) | 2.469 | 1.521–4.006 | <0.001 | 2.921 | 1.809–4.717 | <0.001 |
Vascular invasion (yes vs. no) | 1.803 | 0.899–3.616 | 0.097 | 2.049 | 1.053–3.989 | 0.055 |
Adjacent organ invasion (yes vs. no) | 2.489 | 1.388–4.462 | 0.002 | 3.328 | 1.851–5.984 | <0.001 |
Lymph node metastasis (yes vs. no) | 2.410 | 1.558–3.728 | <0.001 | 2.279 | 1.460–3.558 | <0.001 |
Tumor differentiation (poor vs. moderate vs. well) | 2.009 | 1.366–2.953 | <0.001 | 2.272 | 1.540–3.353 | <0.001 |
Multivariate | ||||||
EYA4 protein expressiona (≤3.4 vs. >3.4) | 1.730 | 1.060–2.823 | 0.028 | 1.781 | 1.093–2.902 | 0.021 |
Number of tumors (multiple vs. single) | 2.008 | 1.201–3.357 | 0.008 | 2.494 | 1.508–4.124 | <0.001 |
Adjacent organ invasion (yes vs. no) | 2.325 | 1.238–4.367 | 0.009 | 3.765 | 1.954–7.253 | 0.001 |
Lymph node metastasis (yes vs. no) | 1.919 | 1.181–3.120 | 0.009 | 1.798 | 1.106–2.921 | 0.018 |
Tumor differentiation (poor vs. moderate vs. well) | 2.053 | 1.301–3.238 | 0.002 | 2.530 | 1.578–4.055 | <0.001 |